Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

about

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

Item

http://www.wikidata.org/entity/Q47103321

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

@en

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

@nl

type

Item

label

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

@en

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

@nl

prefLabel

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

@en

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

@nl

P1476

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

@en

P2093

Karol Charkiewicz

http://www.w3.org/2001/XMLSchema#string

Monika Zbucka-Kretowska

http://www.w3.org/2001/XMLSchema#string

P2860

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1

Identification of proteomic biomarkers of preeclampsia using protein microarray and tandem mass spectrometry

DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways

VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?

Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome

I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo.

Chemokines profiling of patients with preterm birth.

Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome

Role of endogenous angiogenesis inhibitors in Down syndrome.

Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension

P304

e0189762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0189762

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joanna Goscik

Slawomir Wolczynski

Piotr Laudanski

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29244857

http://www.w3.org/2001/XMLSchema#string

P932

5731759

http://www.w3.org/2001/XMLSchema#string